Back to success stories list.
Hunter-Fleming Ltd, a private UK biopharmaceutical company developing new medicines to treat neurodegenerative and inflammatory disorders, has been acquired by Newron Pharmaceuticals S.p.A., a research and development company focused on novel Central Nervous Systme and pain therapies.
The company presented at an investment meeting which was organised by Oxford
Investment Opportunity Network in October.
Website: www.newron.com